Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Cancer Res. 2014 Sep 5;74(21):6184–6193. doi: 10.1158/0008-5472.CAN-14-1357

Fig. 6.

Fig. 6

Molecular mechanism rendering AEG-1KO mice resistant to HCC. A. Functional endpoints, analyzed by Ingenuity pathway analysis, that are inhibited in AEG-1KO mice. Blue line: inhibition; red line: activation; yellow line: finding inconsistent with state of downstream molecules; gray line: effect not predicted. Green color: downregulation of expression; red color: upregulation of expression. B. Schematic representation of the molecular mechanism of resistance of AEG-1KO mice to HCC. In WT mice DEN-induced hepatocyte injury leads to IL-1α production that activates NF-κB in the macrophages leading to production of IL-6. IL-6 activates STAT3 in hepatocytes facilitating proliferation of the mutated cells leading to HCC. In AEG-1KO mice NF-κB activation is inhibited in hepatocytes and macrophages thereby inhibiting IL-6 production and STAT3 activation. As a consequence, HCC development is significantly abrogated.